Drug Patents owned by Impax

1. List of Adrenaclick drug patents

Patent Number Company Patent Title Patent Expiry Activity Alert
These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7297136 IMPAX Medicine injection devices and methods
Jan, 2025

(1 year, 7 months from now)

US10166334 IMPAX Medicine injection apparatuses
Jan, 2025

(1 year, 7 months from now)

US7621891 IMPAX Method and apparatus for delivering epinephrine
Feb, 2025

(1 year, 8 months from now)

US7905352 IMPAX Kits containing medicine injection devices and containers
Apr, 2027

(3 years from now)

Do you want to check out ADRENACLICK patents from before 2022?

Drugs and Companies using EPINEPHRINE ingredient

Market Authorisation Date: 30 May, 2003

Treatment: NA

Dosage: INJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS

More Information on Dosage

ADRENACLICK family patents

17

United States

3

Russia

3

China

3

South Africa

3

Canada

3

Taiwan

3

Norway

3

European Union

2

San Marino

2

Mexico

2

Brazil

2

Japan

2

Australia

1

New Zealand

1

Hong Kong

900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight

Join them to stay ahead in capturing the next drug going generic

Other things you might be interested in